Sangamo Therapeutics
SGMO
#10549
Rank
A$46.31 M
Marketcap
A$0.11
Share price
0.00%
Change (1 day)
-81.51%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2026 (TTM): A-$0.57

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is A-$0.57. In 2025 the company made an earnings per share (EPS) of A-$0.66 an increase over its 2024 EPS that were of A-$0.77.

EPS history for Sangamo Therapeutics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.57-14.58%
2025A-$0.66-13.73%
2024A-$0.77
2022A-$1.890.81%
2021A-$1.8733.33%
2020A-$1.416.9%
2019A-$1.3122.54%
2018A-$1.071.43%
2017A-$1.06-31.37%
2016A-$1.5475.86%
2015A-$0.8848.72%
2014A-$0.59-17.02%
2013A-$0.719.3%
2012A-$0.65-39.44%
2011A-$1.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.09-1,857.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.26-4,673.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.57-721.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A-$1.92 234.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.68 715.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.93-5,313.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A-$0.14-76.32%๐Ÿ‡บ๐Ÿ‡ธ USA